ASC News

Here are seven updates:

Takeda Pharmaceutical's Axcelead Drug Discovery Partners officially began operating on May 15, The Pharma Letter reports.

In 2016, companies made $8.18 billion in payments to physicians and teaching hospitals, according to CMS' Open Payments data.

Outpatient total joint replacements will leap 77 percent over the next decade, while inpatient total joints will only see a 3 percent growth over that period, according to Sg2.

A new study published in Spine examines whether outpatient spinal fusion cases are safe.

Xenco Medical expanded delivery for its ASC CerviKit, a compact delivery and storage platform for anterior cervical discectomy and fusion procedures designed for the ASC setting.

Several aspects go into successful ASCs, but offering a diversified caseload is among the most important.

Orthopedics, ophthalmology and gastroenterology are "the big three" of ambulatory surgery centers and are the driving specialties behind profitable centers.

Serving as the president of Massachusetts Association of Ambulatory Surgery Centers and administrator of Boston Out-Patient Surgical Suites, Gregory DeConciliis says Massachusetts can very well be defined as a hospital-driven town.

Here are seven healthcare updates for ASC leaders to note: